Antiinflammatory therapy in osteoarthritis including omega 3 and omega 6 fatty acids;Leczenie przeciwzapalne w chorobie zwyrodnieniowej stawów z uwzglȩdnieniem kwasów tłuszczowych omega 3 i omega 6

Polski Merkuriusz Lekarski

Volumn 32, Issue 191, 2012, Pages 329-334

  Dzielska Olczak, Małgorzata ^a   Nowak, Jerzy Z ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Dual cyclooxygenases and 5 lipooxy genase inhibitors; Inflammation; NO NSAI omega 3 and omega 6 polyunsaturated fatty acids; Nonselective and selective cyclooxygenases inhibitors; Osteoarthrosis

Indexed keywords

ANTIINFLAMMATORY AGENT; CHONDROITIN SULFATE; GLUCOSAMINE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PARACETAMOL;

DISEASE COURSE; HUMAN; OSTEOARTHRITIS; REVIEW;

ACETAMINOPHEN; ANTI-INFLAMMATORY AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHONDROITIN SULFATES; DISEASE PROGRESSION; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; GLUCOSAMINE; HUMANS; OSTEOARTHRITIS;

EID: 84862669304     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Ameye L.G., Chee W.S.: Osteoarthritis and nutrition. From nutraceuti-cals to functional foods: a systematic review of the scientific evidence. Arthritis Res Ther. 2006; 8(4); R127.
2. Arita M., Bianchini F., Aliberti Jet.al.: Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator reso-Ivin E1. J Exp Med. 2005; 01; 713-722. (Pubitemid 40395117)
3. Calder P.C.: Polyunsaturated fatty acids and inflammatory processes: New twists in an old tale. Biochimie. 2009; 91(6); 791-5.
4. Calder P.C. N-3 polyunsaturated fatty acids and inflammation: from molecular biology to the clinic Lipids. 2003; 38(4); 343-52. (Pubitemid 36724290)
5. Curtis C.L., Hughes C.E., Flannery C.R. et al.: n-3 fatty acids specifically modulate catabolic factors involved in articular cartilage degradation. J Biol Chem. 2000; 275; 721-724 (Pubitemid 30051107)
6. Curtis C.L., Rees S.G., Cramp J. et.al.: Effects of n-3 fatty acids on cartilage metabolism. Proc Nutr Soc. 2002; 61; 381-389 (Pubitemid 34982929)
7. Curtis C.L., Rees S.G., Little C.B. et.al.: Pathologic indicators of degradation and inflammation in human osteoarthritic cartilage are abrogated by exposure to n-3 fatty acids. Arthritis Rheum. 2002; 46; 1544-1553 (Pubitemid 34620201)
8. Davidson M.H.: Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids. Am J Cardiol. 2006; 98(4A); 27i-33i.
9. Deckelbaum R.J., Worgall T.S., Seo T.: n-3 fatty acids and gene expression. Am J Clin Nutr. 2006; 83(6suppl); 1520S-1525S. (Pubitemid 44713093)
10. Dzielska-Olczak M.: Inhibitory cyklooksygenaz i inne zwia̧zkl o potentate przeciwzapalnym w chorobie zwyrodnieniowej stawów (osteoartrozie, OA) - czȩść I. Pol.Merk. Lek., 2011, 175, 75-81.
11. Dzielska-Olczak M.: Inhibitory cyklooksygenaz I inne zwia̧zki o potencja-le przeciwzapalnym w chorobie zwyrodnieniowej stawów (osteoartrozie, OA) - czȩść II. Pol.Merk. Lek., 2011, 175, 82-88.
12. Gruenwald J., Petzold E., Busch R. et.al.: Effect of glucosamine sulfate with or without omega-3 fatty acids in patients with osteoarthritis. Advances in Therapy. 2009; 26(9); 858-871
13. Hankenson K.D., Watkins B.A., Schoenlein I.A. et.al.: Omega-3 fatty acids enhance ligament fibroblast collagen fonvation in association with changes in interleukin-6 production. Proceedings of the Society for Experimental Biology and Medicine. 2000; 223(1); 88-95 (Pubitemid 30182662)
14. Hurst S., Zainal Z., Caterson B. et al.: Dietary fatty acids and arthritis. Prostaglandins Leukot Essent Fatty Acids. 2010; 82(4-6); 315-8. Epub 2010 Marl.
15. Jacquet A., Girodet P.O., Pariente A. et.al.: Phytalgic, a food supplement, vs placebo in patients with osteoarthritis of the knee or hip: a randomised double-blind placebo-controlled clinical trial. Arthritis Res Ther. 2009; 11(6); R192. Epub 2009 Dec 16.
16. L. Knott, N.C. Avery, A.P. Hollander et.al.: Regulation of osteoarthritis by omega-3 (n-3) polyunsaturated fatty acids in a naturally occurring model of disease Osteoarthritis and Cartilage. 2011; 19(9); 1150-7
17. LippielloL., Fienhold M., Grandjean C: Metabolic and ultrastructural changes in articular cartilage of rats fed dietary supplements of omega-3 fatty acids. Arthritis & Rheumatism. 1990; 33(7); 1029-1036 (Pubitemid 20226358)
18. Lippiello L., Walsh T., Fienhold M.: The association of lipid abnormalities with tissue pathology in human osteoarthritic articular cartilage. Metabolism. 1991; 40; 571-576
19. Maderna P., Godson C: Lipoxins: resolutionary road. Br J Pharmacol. 2009; 158(4), 947-59
20. Mori T.A., Beilin L.J., Burke V. et.al.: Interactions between dietary fat, fish, and fish oils and their effects on platelet function in men at risk of cardiovascular disease. Arterioscler Thromb Vase Biol. 1997; 17(2); 279-86. (Pubitemid 27098185)
21. Nah S.S., Choi I.Y., Lee C.K. et.al.: Effects of advanced glycation end products on the expression of COX-2, PGE2 and NO in human osteoarthritic chondrocytes. Rheumatology (Oxford). 2008; 47(4); 425-31. Epub 2008 Feb 19.
22. Nowak J.Z.: Przeciwzapalne "pmwygaszeniowe" pochodne wieloniena-syconych kwasów tluszczowych omega 3 I omega 6. Postȩpy Hig Med Dośw., 2010; 64; 115-132.
23. Nowak J.Z.: Zapalenie: ostre, przewlekle, para-inflammation - nowe kon-cepeje, nowe lekl. Mag Lek Okul.2011; 5(4); 194-211
24. Oh da Y., Talukdar S., Bae E.J. et.al.: GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. JM. Cell. 2010; 42(5); 687-98.
25. Roush J.K., Cross A.R., Renberg W.C. et.al.: Evaluation of the effects of dietary supplementation with fish oil omega-3 fatty acids on weight bearing in dogs with osteoarthritis J Am Vet Med Assoc. 2010; 236(1); 67-73.
26. Roush J.K., Dodd C.E., Fritsch D.A. et.al.: Multicenter veterinary practice assessment of the effects of omega-3 fatty acids on osteoarthritis in dogs. J Am Vet Med Assoc. 2010; 236(1); 59-66.
27. Schaefer E.J., Bongard V., Beiser A.S. et.al.: Plasma phosphatidyl-choline docosahexaenoic acid content and risk of dementia and Al-zheimer disease: the Framingham Heart Study. Arch Neurol. 2006; 63; 1545-50 (Pubitemid 44748796)
28. Stammers T., Sibbald B., Freeling P.: Efficacy of cod liver oil as an adjunct to non-steroidal anti-inflammatory drug treatment in the management of osteoarthritis in general practice. Ann Rheum Dis. 1992; 51; 128-129
29. Tattersall A.L., Wilkins R J.: Effects of hexosamines and omega-3/ome-ga-6 fatty acids on pH regulation by interieukin 1-treated isolated bovine articular chondrocytes.Ptiugers Arch. 2008; 456(3); 501-6. Epub 2008 Jan 17
30. Wang Y., Wluka A.E., Hodge A.M. et.al.: Effecf of fatty acids on bone marrow lesions and knee cartilage in healthy, middle-aged subjects without clinical knee osteoarthritis. Osteoarthritis Cartilage. 2008; 16(5); 579-83. Epub 2007 Oct 15. (Pubitemid 351524698)
31. Wann A.K., Mistry J., Blain E.J. et.al.: Eicosapentaenoic acid and docosahexaenoic acid reduce interieukin-1 β-mediated cartilage degradation. Arthritis Res Ther. 2010; 12(6); R207. Epub 2010 Nov 8.
32. Zainal Z., Longman A.J., Hurst S. et.al.: Relative efficacies of omega-3 polyunsaturated fatty acids in reducing expression of key proteins in a model system for studying osteoarthritis.Osteoarthritis Cartilage. 2009; 17(7); 896-905. Epub 2009 Jan 13.